Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 127 results.
User Information
Export Records
  1. 1.   Redox Epiphospholipidome in Programmed Cell Death Signaling: Catalytic Mechanisms and Regulation
  2. Kagan, Valerian E.; Tyurina, Yulia Y.; Vlasova, Irina I.; Kapralov, Alexander A.; Amoscato, Andrew A.; Anthonymuthu, Tamil S.; Tyurin, Vladimir A.; Shrivastava, Indira H.; Cinemre, Fatma B.; Lamade, Andrew; Epperly, Michael W.; Greenberger, Joel S.; Beezhold, Donald H.; Mallampalli, Rama K.; Srivastava, Apurva K.; Bayir, Hulya; Shvedova, Anna A.
  3. Frontiers in Endocrinology. 2021, Feb 19; 11
  1. 2.   Isolation and Functional Analysis of Human Neutrophils
  2. Kuhns, D. B.; Long Priel, D. A.; Chu, J.; Zarember, K. A.
  3. Current Protocols in Immunology. 2015, 2-Nov; 111: 7.23.1-16.
  1. 3.   Carboxyl-terminal modulator protein induces apoptosis by regulating mitochondrial function in lung cancer cells
  2. Hwang, S. K.; Minai-Tehrani, A.; Yu, K. N.; Chang, S. H.; Kim, J. E.; Lee, K. H.; Park, J.; Beck, G. R.; Cho, M. H.
  3. International Journal of Oncology. 2012, May; 40(5): 1515-1524.
  1. 4.   JS-K, a Glutathione S-Transferase-Activated Nitric Oxide Donor With Antineoplastic Activity in Malignant Gliomas
  2. Weyerbrock, A.; Osterberg, N.; Psarras, N.; Baumer, B.; Kogias, E.; Werres, A.; Bette, S.; Saavedra, J. E.; Keefer, L. K.; Papazoglou, A.
  3. Neurosurgery. 2012, Feb; 70(2): 497-510.
  1. 5.   One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)thiazole: A unique, highly active antimicrotubule agent
  2. Romagnoli, R.; Baraldi, P. G.; Cara, C. L.; Salvador, M. K.; Bortolozzi, R.; Basso, G.; Viola, G.; Balzarini, J.; Brancale, A.; Fu, X. H.; Li, J.; Zhang, S. Z.; Hamel, E.
  3. European Journal of Medicinal Chemistry. 2011, Dec; 46(12): 6015-6024.
  1. 6.   Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer
  2. Koutros, S.; Andreotti, G.; Berndt, S. I.; Barry, K. H.; Lubin, J. H.; Hoppin, J. A.; Kamel, F.; Sandler, D. P.; Burdette, L. A.; Yuenger, J.; Yeager, M.; Alavanja, M. C. R.; Freeman, L. E. B.
  3. Pharmacogenetics and Genomics. 2011, Oct; 21(10): 615-623.
  1. 7.   Population pharmacokinetic analysis of sorafenib in patients with solid tumours
  2. Jain, L.; Woo, S.; Gardner, E. R.; Dahut, W. L.; Kohn, E. C.; Kummar, S.; Mould, D. R.; Giaccone, G.; Yarchoan, R.; Venitz, J.; Figg, W. D.
  3. British Journal of Clinical Pharmacology. 2011, Aug; 72(2): 294-305.
  1. 8.   Isolation and Characterization of the CYP2D6 Gene in Felidae with Comparison to Other Mammals
  2. Schenekar, T.; Winkler, K. A.; Troyer, J. L.; Weiss, S.
  3. Journal of Molecular Evolution. 2011, Feb; 72(2): 222-231.
  1. 9.   Insulin-like growth factor 1 receptor antibody induces rhabdomyosarcoma cell death via a process involving AKT and Bcl-x(L)
  2. Mayeenuddin, L. H.; Yu, Y.; Kang, Z.; Helman, L. J.; Cao, L.
  3. Oncogene. 2010, Dec; 29(48): 6367-6377.
  1. 10.   Hematologically important mutations: X-linked chronic granulomatous disease (third update)
  2. Roos, D.; Kuhns, D. B.; Maddalena, A.; Roesler, J.; Lopez, J. A.; Ariga, T.; Avcin, T.; de Boer, M.; Bustamante, J.; Condino-Neto, A.; Di Matteo, G.; He, J. X.; Hill, H. R.; Holland, S. M.; Kannengiesser, C.; Koker, M. Y.; Kondratenko, I.; van Leeuwen, K.; Malech, H. L.; Marodi, L.; Nunoi, H.; Stasia, M. J.; Ventura, A. M.; Witwer, C. T.; Wolach, B.; Gallin, J. I.
  3. Blood Cells Molecules and Diseases. 2010, Oct; 45(3): 246-265.
  1. 11.   Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 alpha Expression in an AhR-Independent Fashion
  2. Terzuoli, E.; Puppo, M.; Rapisarda, A.; Uranchimeg, B.; Cao, L. A.; Burger, A. M.; Ziche, M.; Melillo, G.
  3. Cancer Research. 2010, Sep 1; 70(17): 6837-6848.
  1. 12.   Synthesis and Antitumor Activity of 1,5-Disubstituted 1,2,4-Triazoles as Cis-Restricted Combretastatin Analogues
  2. Romagnoli, R.; Baraldi, P. G.; Cruz-Lopez, O.; Cara, C. L.; Carrion, M. D.; Brancale, A.; Hamel, E.; Chen, L. C.; Bortolozzi, R.; Basso, G.; Viola, G.
  3. Journal of Medicinal Chemistry. 2010, May; 53(10): 4248-4258.
  1. 13.   Energetic determinants of protein binding specificity: Insights into protein interaction networks
  2. Carbonell, P.; Nussinov, R.; del Sol, A.
  3. Proteomics. 2009 9(7): 1744-1753.
  1. 14.   Structural Basis for Phototoxicity of the Genetically Encoded Photosensitizer KillerRed
  2. Pletnev, S.; Gurskaya, N. G.; Pletneva, N. V.; Lukyanov, K. A.; Chudakov, D. M.; Martynov, V. I.; Popov, V. O.; Kovalchuk, M. V.; Wlodawer, A.; Dauter, Z.; Pletnev, V.
  3. Journal of Biological Chemistry. 2009 284(46): 32028-32039.
  1. 15.   Aryl Hydrocarbon Receptor Expression Is Associated with a Family History of Upper Gastrointestinal Tract Cancer in a High-Risk Population Exposed to Aromatic Hydrocarbons
  2. Roth, M. J.; Wei, W. Q.; Baer, J.; Abnet, C. C.; Wang, G. Q.; Sternberg, L. R.; Warner, A. C.; Johnson, L. L.; Lu, N.; Giffen, C. A.; Dawsey, S. M.; Qiao, Y. L.; Cherry, J.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(9): 2391-2396.
  1. 16.   Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects
  2. Robertson, S. M.; Maldarelli, F.; Natarajan, V.; Formentini, E.; Alfaro, R. M.; Penzak, S. R.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2008 49(5): 513-519.
  1. 17.   The C-terminal transmembrane domain of Bcl-x(L) mediates changes in mitochondrial morphology
  2. Zheng, J. Y.; Tsai, Y. C.; Kadimcherla, P.; Zhang, R.; Shi, J.; Oyler, G. A.; Boustany, N. N.
  3. Biophysical Journal. 2008 94(1): 286-297.
  1. 18.   Caspase-dependent cleavage disrupts the ERK cascade scaffolding function of KSR1
  2. McKay, M. M.; Morrison, D. K.
  3. Journal of Biological Chemistry. 2007, Sep; 282(36): 26225-26234.
  1. 19.   A novel synthetic analogue of a constituent of Isodon excisus inhibits transcription of CYP1A1,-1A2 and-1B1 by preventing activation of the aryl hydrocarbon receptor
  2. Sienkiewicz, P.; Ciolino, H. P.; Leslie, B. J.; Hergenrother, P. J.; Singletary, K.; Yeh, G. C.
  3. Carcinogenesis. 2007, May; 28(5): 1052-1057.
  1. 20.   The pregnane X receptor gene-humanized mouse: A model for investigating drug-drug interactions mediated by cytochromes P450 3A
  2. Ma, X.; Shah, Y.; Cheung, C.; Guo, G. L.; Feigenbaum, L.; Krausz, K. W.; Idle, J. R.; Gonzalez, F. J.
  3. Drug Metabolism and Disposition. 2007, Feb; 35(2): 194-200.
  1. 21.   Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines
  2. Glover, C. J.; Rabow, A. A.; Isgor, Y. G.; Shoemaker, R. H.; Covell, D. G.
  3. Biochemical Pharmacology. 2007, Feb; 73(3): 331-340.
  1. 22.   Modular architecture of protein structures and allosteric communications: potential implications for signaling proteins and regulatory linkages
  2. del Sol, A.; Arauzo-Bravo, M. J.; Moya, D. A.; Nussinov, R.
  3. Genome Biology. 2007 8(5):
  1. 23.   Overexpression of proline oxidase induces proline-dependent and mitochondria-mediated apoptosis
  2. Hu, C. A. A.; Donald, S. P.; Yu, J.; Lin, W. W.; Liu, Z. H.; Steel, G.; Obie, C.; Valle, D.; Phang, J. M.
  3. Molecular and Cellular Biochemistry. 2007, Jan; 295(1-2): 85-92.
  1. 24.   Inactivation of oxidized and S-nitrosylated mitochondrial proteins in alcoholic fatty liver of rats
  2. Moon, K. H.; Hood, B. L.; Kim, B. J.; Hardwick, J. P.; Conrads, T. P.; Veenstra, T. D.; Song, B. Y. J.
  3. Hepatology. 2006, Nov; 44(5): 1218-1230.
  1. 25.   JS-K, a nitric oxide prodrug, induces cytochrome c release and caspase activation in HL-60 myeloid leukemia cells
  2. Udupi, V.; Yu, M.; Malaviya, S.; Saavedra, J. E.; Shami, P. J.
  3. Leukemia Research. 2006, Oct; 30(10): 1279-1283.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel